Multinational observational study to describe diagnostic stage shift in patients with lung cancer using medical records

Trial Identifier:	D133HR00049
Sponsor:	AstraZeneca
Start Date:	April 2027
Primary Completion Date:	March 2030
Study Completion Date:	March 2030
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.